Researchers will study whether abnormal amounts of DNA and other biological changes in cells collected with an oral brush can help identify lesions that need closer evaluation. Following these changes over time may improve understanding of oral cancer risk and...
News
This award continues a comprehensive cancer screening program that has enrolled more than 100 people with FA. By combining regular screening with the collection of samples over time, researchers aim to better understand how cancer develops and identify potential early...
This clinical study examines the safety and tolerability of metformin and naproxen as potential approaches to oral cancer prevention in people with FA. Participants take the medications during separate study periods. Researchers will monitor side effects and changes in oral...
People with Fanconi anemia (FA) face a high risk of cancer, but their difficulty repairing DNA can make some cancer treatments especially harmful. This project examines two questions: Which compounds might help prevent cancer, and which cancer treatment drugs might...
People with Fanconi anemia (FA) face a high risk of oral cancer. This project asks whether gene therapy delivered to the tissue lining the mouth could someday reduce that risk by helping cells repair DNA more effectively. FCF funding supports...
Cancer care in Fanconi anemia (FA) is complex, and information about diagnosis, treatment and outcomes is often scattered across individual cases. This project will bring together medical records from people whose cases were presented to FCF’s Virtual Tumor Board and...